Literature DB >> 20138112

Astrocytic beta(2)-adrenergic receptors: from physiology to pathology.

Guy Laureys1, Ralph Clinckers, Sarah Gerlo, Anneleen Spooren, Nadine Wilczak, Ron Kooijman, Ilse Smolders, Yvette Michotte, Jacques De Keyser.   

Abstract

Evidence accumulates for a key role of the beta(2)-adrenergic receptors in the many homeostatic and neuroprotective functions of astrocytes, including glycogen metabolism, regulation of immune responses, release of neurotrophic factors, and the astrogliosis that occurs in response to neuronal injury. A dysregulation of the astrocytic beta(2)-adrenergic-pathway is suspected to contribute to the physiopathology of a number of prevalent and devastating neurological conditions such as multiple sclerosis, Alzheimer's disease, human immunodeficiency virus encephalitis, stroke and hepatic encephalopathy. In this review we focus on the physiological functions of astrocytic beta(2)-adrenergic receptors, and their possible impact in disease states.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138112     DOI: 10.1016/j.pneurobio.2010.01.011

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  24 in total

1.  The impact of glial activation in the aging brain.

Authors:  Aileen M Lynch; Kevin J Murphy; Brian F Deighan; Julie-Ann O'Reilly; Yuri K Gun'ko; Thelma R Cowley; Rodrigo E Gonzalez-Reyes; Marina A Lynch
Journal:  Aging Dis       Date:  2010-09-04       Impact factor: 6.745

Review 2.  Astroglial vesicular network: evolutionary trends, physiology and pathophysiology.

Authors:  R Zorec; V Parpura; A Verkhratsky
Journal:  Acta Physiol (Oxf)       Date:  2017-08-03       Impact factor: 6.311

3.  Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation.

Authors:  Adam G Walker; Douglas J Sheffler; Andrew S Lewis; Jonathan W Dickerson; Daniel J Foster; Rebecca K Senter; Mark S Moehle; Xiaohui Lv; Branden J Stansley; Zixiu Xiang; Jerri M Rook; Kyle A Emmitte; Craig W Lindsley; P Jeffrey Conn
Journal:  Neuropsychopharmacology       Date:  2017-06-30       Impact factor: 7.853

Review 4.  Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

Authors:  Yunqi Xu; Junqiang Yan; Peng Zhou; Jiejie Li; Huimin Gao; Ying Xia; Qing Wang
Journal:  Prog Neurobiol       Date:  2012-02-25       Impact factor: 11.685

5.  β2-adrenergic receptor and astrocyte glucose metabolism.

Authors:  Jun-hong Dong; Xin Chen; Min Cui; Xiao Yu; Qi Pang; Jin-peng Sun
Journal:  J Mol Neurosci       Date:  2012-03-08       Impact factor: 3.444

Review 6.  Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets.

Authors:  Kjell Fuxe; Luigi F Agnati; Manuela Marcoli; Dasiel O Borroto-Escuela
Journal:  Neurochem Res       Date:  2015-04-17       Impact factor: 3.996

Review 7.  Autonomic dysfunction, immune regulation, and multiple sclerosis.

Authors:  Juan Manuel Racosta; Kurt Kimpinski
Journal:  Clin Auton Res       Date:  2015-12-21       Impact factor: 4.435

Review 8.  Beta2-Adrenoceptor Agonists in Parkinson's Disease and Other Synucleinopathies.

Authors:  Luca Magistrelli; Cristoforo Comi
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-07       Impact factor: 4.147

Review 9.  Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.

Authors:  W Gibson Wood; Ling Li; Walter E Müller; Gunter P Eckert
Journal:  J Neurochem       Date:  2014-01-02       Impact factor: 5.372

Review 10.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.